WO2020116892A3 - 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법 - Google Patents

생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법 Download PDF

Info

Publication number
WO2020116892A3
WO2020116892A3 PCT/KR2019/016916 KR2019016916W WO2020116892A3 WO 2020116892 A3 WO2020116892 A3 WO 2020116892A3 KR 2019016916 W KR2019016916 W KR 2019016916W WO 2020116892 A3 WO2020116892 A3 WO 2020116892A3
Authority
WO
WIPO (PCT)
Prior art keywords
nano
lipid carrier
encapsulation
bioactive material
producing same
Prior art date
Application number
PCT/KR2019/016916
Other languages
English (en)
French (fr)
Other versions
WO2020116892A2 (ko
Inventor
김유미
장기현
Original Assignee
(주) 바이노텍
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by (주) 바이노텍 filed Critical (주) 바이노텍
Priority to US17/279,551 priority Critical patent/US11826474B2/en
Priority to EP19893929.0A priority patent/EP3842027A4/en
Publication of WO2020116892A2 publication Critical patent/WO2020116892A2/ko
Publication of WO2020116892A3 publication Critical patent/WO2020116892A3/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5015—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11—Encapsulated compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/06—Tripeptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64—Proteins; Peptides; Derivatives or degradation products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
    • A61K8/81—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds obtained by reactions involving only carbon-to-carbon unsaturated bonds
    • A61K8/8141—Compositions of homopolymers or copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and at least one being terminated by only one carboxyl radical, or of salts, anhydrides, esters, amides, imides or nitriles thereof; Compositions of derivatives of such polymers
    • A61K8/8147—Homopolymers or copolymers of acids; Metal or ammonium salts thereof, e.g. crotonic acid, (meth)acrylic acid; Compositions of derivatives of such polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5089—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5192—Processes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/14—Drugs for dermatological disorders for baldness or alopecia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/41—Particular ingredients further characterized by their size
    • A61K2800/413—Nanosized, i.e. having sizes below 100 nm
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/56—Compounds, absorbed onto or entrapped into a solid carrier, e.g. encapsulated perfumes, inclusion compounds, sustained release forms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
    • A61K2800/805—Corresponding aspects not provided for by any of codes A61K2800/81 - A61K2800/95

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Optics & Photonics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Physics & Mathematics (AREA)
  • Biomedical Technology (AREA)
  • Nanotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Dispersion Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Cosmetics (AREA)

Abstract

본 발명은 생리활성 물질 봉입을 위한 입자성 나노지질전달체 및 이의 제조방법에 관한 것으로, 보다 상세하게는 나노 입자 안정성이 우수하고 수용성 약물의 봉입이 향상된 입자성 나노지질전달체에 관한 것으로, 본 발명에 따른 나노지질전달체는 종래 전달체 대비 생리활성물질의 안정성과 봉입 효율이 현저히 향상되었으며, 대량생산에 적합한 모낭 타게팅 제조방법으로 본 발명을 통한 나노지질전달체를 화장품 원료로 바로 상용화가 가능할 것으로 기대된다.
PCT/KR2019/016916 2018-12-07 2019-12-03 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법 WO2020116892A2 (ko)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US17/279,551 US11826474B2 (en) 2018-12-07 2019-12-03 Nano-lipid carrier for encapsulation of bioactive material, and method for producing same
EP19893929.0A EP3842027A4 (en) 2018-12-07 2019-12-03 NANOLIPID CARRIER FOR BIOACTIVE MATERIAL ENCAPSULATION AND PROCESS FOR ITS PRODUCTION

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180157119A KR102037354B1 (ko) 2018-12-07 2018-12-07 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법
KR10-2018-0157119 2018-12-07

Publications (2)

Publication Number Publication Date
WO2020116892A2 WO2020116892A2 (ko) 2020-06-11
WO2020116892A3 true WO2020116892A3 (ko) 2021-04-22

Family

ID=68421964

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/KR2019/016916 WO2020116892A2 (ko) 2018-12-07 2019-12-03 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법

Country Status (4)

Country Link
US (1) US11826474B2 (ko)
EP (1) EP3842027A4 (ko)
KR (1) KR102037354B1 (ko)
WO (1) WO2020116892A2 (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102037354B1 (ko) 2018-12-07 2019-10-28 (주) 바이노텍 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법
KR102309888B1 (ko) * 2020-01-08 2021-10-07 (주)에이티 랩 피부 투과 성능이 향상된 리포좀.
KR102299769B1 (ko) * 2020-01-23 2021-09-09 (주)에이티 랩 피부 투과 성능이 향상된 리포좀의 제조방법.
KR102370679B1 (ko) * 2021-06-30 2022-03-11 (주)아쿠아렉스 피부주름 개선용 화장료 조성물 및 그 제조방법
KR102522864B1 (ko) * 2022-08-17 2023-04-19 주식회사 리더스코스메틱 표피-진피 접합부를 강화하는 나노입자 제조방법 및 이를 함유하는 화장료 조성물
KR102510870B1 (ko) * 2022-12-14 2023-03-17 유스킨컴퍼니 주식회사 펩타이드를 포함하는 육모촉진용 조성물
KR102632679B1 (ko) * 2023-06-25 2024-02-02 (주) 바이노텍 히알루론산 봉입 나노 입자 전달체 및 이의 제조방법
CN118078674B (zh) * 2024-04-24 2024-07-09 杭州湃肽生化科技有限公司 包封蓝铜肽或其组合物的脂质体及其在生发中的用途

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544155A (ja) * 1999-05-07 2002-12-24 ファルマソル ゲーエムベーハー 流体および固体脂質の混合物を基礎とする脂質粒子、およびそれらを製造するための方法
KR20070091443A (ko) * 2006-03-06 2007-09-11 (주)아모레퍼시픽 하이드록시프로필-베타사이클로 덱스트린을 이용하여가용화된 유용성 생리활성성분을 담지하는 고분자-리포좀나노복합체
KR101810160B1 (ko) * 2017-06-30 2018-01-25 주식회사 셀리제코스메틱 생리활성물질이 봉입된 에토좀 제조 방법, 에토좀 조성물 및 에토좀 조성물을 포함하는 화장료 조성물
KR20180097368A (ko) * 2017-02-23 2018-08-31 김현성 펩타이드를 함유하는 리포좀 조성물
KR102037354B1 (ko) * 2018-12-07 2019-10-28 (주) 바이노텍 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101054731B1 (ko) 2004-06-16 2011-08-05 (주)아모레퍼시픽 난용성 발모 및 육모 생리활성 물질인 피나스테라이드를포함하는 나노입자 및 이를 함유하는 피부 외용제 조성물
ES2384060B1 (es) 2010-03-24 2013-09-23 Lipotec S.A. Cápsulas de nanopartículas lipídicas.
KR101377710B1 (ko) 2012-02-02 2014-03-21 강원대학교산학협력단 천연 추출물의 양모효능을 촉진시키는 큐빅상 나노입자 및 그 제조방법
WO2019023873A1 (zh) * 2017-07-31 2019-02-07 江苏竞诺择生物医药科技有限公司 一种用于治疗造血系统增殖性疾病的纳米脂质微粒组合物及药用组合物
KR101851388B1 (ko) * 2017-08-25 2018-06-07 주식회사 세화 피앤씨 진세노사이드의 경피흡수 촉진용 조성물, 이의 제조방법 및 상기 조성물을 함유하는 탈모방지 화장료 조성물
CN108785141A (zh) * 2018-09-14 2018-11-13 广州优刻生物科技有限公司 一种美容液、制备方法及其应用
CN108938456A (zh) * 2018-10-09 2018-12-07 泓博元生命科技（深圳）有限公司 一种组合物及其制备方法及应用

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002544155A (ja) * 1999-05-07 2002-12-24 ファルマソル ゲーエムベーハー 流体および固体脂質の混合物を基礎とする脂質粒子、およびそれらを製造するための方法
KR20070091443A (ko) * 2006-03-06 2007-09-11 (주)아모레퍼시픽 하이드록시프로필-베타사이클로 덱스트린을 이용하여가용화된 유용성 생리활성성분을 담지하는 고분자-리포좀나노복합체
KR20180097368A (ko) * 2017-02-23 2018-08-31 김현성 펩타이드를 함유하는 리포좀 조성물
KR101810160B1 (ko) * 2017-06-30 2018-01-25 주식회사 셀리제코스메틱 생리활성물질이 봉입된 에토좀 제조 방법, 에토좀 조성물 및 에토좀 조성물을 포함하는 화장료 조성물
KR102037354B1 (ko) * 2018-12-07 2019-10-28 (주) 바이노텍 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법

Also Published As

Publication number Publication date
US20210338594A1 (en) 2021-11-04
US11826474B2 (en) 2023-11-28
EP3842027A2 (en) 2021-06-30
WO2020116892A2 (ko) 2020-06-11
KR102037354B1 (ko) 2019-10-28
EP3842027A4 (en) 2022-09-07

Similar Documents

Publication Publication Date Title
WO2020116892A3 (ko) 생리활성물질 봉입을 위한 나노지질전달체 및 이의 제조방법
WO2015017478A3 (en) SYNTHESIS OF CdSe/ZnS CORE/SHELL SEMICONDUCTOR NANOWIRES
MX2020008823A (es) Proceso para preparar microcapsulas.
WO2015039053A3 (en) Highly efficient synthesis of long rna using reverse direction approach
MX2015015909A (es) Metodo para lograr mejor reologia, deposito y aceptacion cosmetica del producto por parte del consumidor.
WO2017123763A8 (en) Processes for the preparation of 2,5-furandicarboxylic acid and intermediates and derivatives thereof
WO2019147749A3 (en) Stabilized rsv f proteins and uses thereof
MX2021006873A (es) Proceso para la preparacion de microcapsulas de poliamida.
EP3395321A3 (en) Compositions for personal care comprising botanical powder as active compound and delivery system
SG11201900277RA (en) Bio-cellulose sheet, bio-cellulose sheet product, and method for producing bio-cellulose sheet and bio-cellulose sheet product
MX2019002682A (es) Microcapsulas hibridas.
WO2016098910A8 (en) Composite particle and preparation thereof
MX2019000609A (es) Proceso para preparacion de microcapsulas.
BR112012021372B8 (pt) processo para produção de nanopartículas, nanopartícula produzida pelo referido processo, composição e gênero alimentício
WO2014178078A3 (en) Novel cloning, expression & purification method for the preparation of ranibizumab
WO2011019481A3 (en) Antiperspirant emulsion products and processes for making the same
MY190407A (en) Method of producing concentrated or dried acid-gellable whey protein aggregates, and related compositions and food products
TR201906966T4 (tr) Hibrit karbon siyahı parçacıklarının imalatı için yöntem ve tertibat.
AU2014224456A8 (en) Novel abexinostate salt, associated crystalline form, preparation method thereof and the pharmaceutical compositions containing same
SG11201806152XA (en) Process for preparing polyamide powders by precipitation
MX2017009358A (es) Proceso para la preparacion de microcapsulas libres de melamina-formaldehido.
MX2023002952A (es) Proceso de preparacion de microcapsulas.
MX2019010228A (es) Composición para liberación controlada de sustancias fisiológicamente activas y proceso para su preparación.
RU2011123622A (ru) Способ изготовления керамического проппанта и проппант
WO2015015445A3 (en) Process for preparing synthetic para-eugenol

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 19893929

Country of ref document: EP

Kind code of ref document: A2

ENP Entry into the national phase

Ref document number: 2019893929

Country of ref document: EP

Effective date: 20210325

NENP Non-entry into the national phase

Ref country code: DE